MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 2.3% of their position (3.40K shares) of NATERA, INC. on the open market
Open‑market sale worth $693.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−405.00
Price / share
$206.16
Trade value
$83.49K
% of position
Common Stock
Shares
−560.00
Price / share
$200.95
Trade value
$112.53K
% of position
Common Stock
Shares
−520.00
Price / share
$201.60
Trade value
$104.83K
% of position
Common Stock
Shares
−505.00
Price / share
$203.32
Trade value
$102.67K
% of position
Common Stock
Shares
−865.00
Price / share
$204.47
Trade value
$176.86K
% of position
Common Stock
Shares
−400.00
Price / share
$205.31
Trade value
$82.12K
% of position
Common Stock
Shares
−150.00
Price / share
$206.93
Trade value
$31.04K
% of position
Net shares
−3.40K
Net value
-$693.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −405.00 | $206.16 | $83.49K | 0.3% | 145.70K | 145.29K |
| Common Stock Direct | 5/1/2026 | S · Sale | −560.00 | $200.95 | $112.53K | 0.4% | 145.29K | 144.74K |
| Common Stock Direct | 5/1/2026 | S · Sale | −520.00 | $201.60 | $104.83K | 0.4% | 144.74K | 144.22K |
| Common Stock Direct | 5/1/2026 | S · Sale | −505.00 | $203.32 | $102.67K | 0.4% | 144.22K | 143.71K |
| Common Stock Direct | 5/1/2026 | S · Sale | −865.00 | $204.47 | $176.86K | 0.6% | 143.71K | 142.84K |
| Common Stock Direct | 5/1/2026 | S · Sale | −400.00 | $205.31 | $82.12K | 0.3% | 142.84K | 142.44K |
| Common Stock Direct | 5/1/2026 | S · Sale | −150.00 | $206.93 | $31.04K | 0.1% | 142.44K | 142.29K |
| Total | −3.40K | -$693.56K | ||||||